These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 651088
1. [Monocomponent insulin: general considerations]. Rodriguez-Miñon JL, Rios MS. Journ Annu Diabetol Hotel Dieu; 1978; ():109-22. PubMed ID: 651088 [No Abstract] [Full Text] [Related]
2. [Insulin lipoatrophy and its elimination through the use of monocomponent insulin]. Maaz E. Z Gesamte Inn Med; 1976 Nov 15; 31(22):941-5. PubMed ID: 1035452 [Abstract] [Full Text] [Related]
3. [Dermatological aspects of diabetes mellitus]. Shcherbak AV. Sov Med; 1985 Nov 15; (2):29-33. PubMed ID: 3887584 [No Abstract] [Full Text] [Related]
4. Current status of insulin in the treatment of diabetes mellitus. Tripathy BB. J Indian Med Assoc; 1973 Jul 01; 61(1):45-8. PubMed ID: 4759071 [No Abstract] [Full Text] [Related]
5. [Experiences with monocomponent insulin treatment]. Korp W, Levett RE. Wien Klin Wochenschr; 1973 May 04; 85(18):326-30. PubMed ID: 4699490 [No Abstract] [Full Text] [Related]
6. Immunologic sensitization of circulating basophils to exogenous insulin in diabetic patients. Emanuelli G, Gatti G, Calcamuggi G, Anfossi G, Cotto A, Marcarino C, Camussi G, Ottone G. Panminerva Med; 1981 May 04; 23(2):81-8. PubMed ID: 7033894 [No Abstract] [Full Text] [Related]
7. Comparative trials with monocomponent (MC) and monospecies (MS) pork insulins in the treatment of diabetes mellitus. Influence on antibody levels, on insulin requirement and on some complications. Andreani D, Iavicoli M, Tamburrano G, Menzinger G, Maltarello C. Horm Metab Res; 1974 Nov 04; 6(6):447-54. PubMed ID: 4476720 [No Abstract] [Full Text] [Related]
8. [Immunological problems in diabetes mellitus]. Boos R. Med Klin; 1969 Aug 22; 64(34):1492-6. PubMed ID: 4390846 [No Abstract] [Full Text] [Related]
9. [The place of "monocomponent" insulins in diabetes mellitus therapy]. Teuscher A. Schweiz Med Wochenschr; 1975 Apr 19; 105(16):485-94. PubMed ID: 1215860 [Abstract] [Full Text] [Related]
10. [Advantages and drawbacks of human insulin]. Zenobi PD. Schweiz Med Wochenschr; 1991 Apr 06; 121(14):475-81. PubMed ID: 2035004 [Abstract] [Full Text] [Related]
12. [Significance of the preparative insulin chemistry for clinical diabetology]. Petrides P. Dtsch Med Wochenschr; 1973 Nov 23; 98(47):2256-8. PubMed ID: 4271376 [No Abstract] [Full Text] [Related]
13. [Proceedings: Formation of anti-insulin antibodies IgG in diabetic patients treated with conventional insulin monocomposed or monospecific]. Weber HU, Sourisseau D, Zahnd GR. Helv Med Acta; 1974 May 23; 37(5-6):367. PubMed ID: 4410557 [No Abstract] [Full Text] [Related]
14. [Single-peak and monocomponent insulins]. Dorner M, Kuntzmann F, Pinget M. Rev Prat; 1978 Sep 21; 28(41):3095-8, 3101-2. PubMed ID: 715348 [No Abstract] [Full Text] [Related]
17. Treatment of insulin allergy and insulin resistance with phenylated insulin. Katsilambros L. Isr J Med Sci; 1972 Jun 23; 8(6):893. PubMed ID: 4538151 [No Abstract] [Full Text] [Related]